digest
Short Summary
Main recommendation: Dr. Suneel Dhand says he would never use Ozempic (semaglutide) for weight loss in people without diabetes, and instead recommends a lifestyle approach focused on diet and activity. He argues the drug's side effects, muscle loss, cost, unknown long-term risks, and failure to address the "toxic food environment" make it a poor shortcut.
Key Points
- Ozempic (semaglutide), a GLP-1 agonist also sold as Wegovy, is being widely used for weight loss by people who are overweight or obese but do not have diabetes, often through med spas with limited oversight.
- Common disabling side effects include nausea, abdominal pain, vomiting, diarrhea, and constipation, because the drug slows the stomach.
- Many users lose muscle as well as fat, which he says is metabolically harmful (sarcopenia) and can leave people looking gaunt.
- The drug costs thousands of dollars, is unlikely to be covered by insurance soon, and is hard to sustain long term; he says stopping usually leads to rapid weight regain.
- He is concerned about unknown long-term effects on the pancreas and possible inflammation or malignancy, since the drug is new and prescribed to a large population.
Details Worth Noting
- Concrete instructions: The video gives no step-by-step medical protocol. The actionable advice is to address lifestyle first: eat real, less processed food, reduce ultra-processed foods, carbs, and sugars, avoid seed oils and artificial ingredients, increase physical activity and exercise, lift weights, consume enough protein to preserve muscle, and consider a personal trainer and motivational support, which he says would cost less than Ozempic.
- He cites a statistic he heard that covering Ozempic for every overweight or obese American would cost more than the country's GDP, about several trillion dollars.
- He compares the problem to addiction and says food companies design highly addictive products, using scientists similar to those who once worked for Big Tobacco.
- He states that about 70% of calorie intake in the United States comes from ultra-processed food, and that the figure is not far off in other Western countries such as the UK.
- He says most people using the drug for weight loss are not making lasting lifestyle changes, which is why weight returns after stopping, and he stresses that everyone is free to make their own health decisions.
Bottom Line
Dr. Dhand's view is that Ozempic is a risky shortcut that treats the appetite symptom rather than the food environment behind weight gain, so he would choose lifestyle change for himself while acknowledging that individuals can weigh the risks themselves.
